Results 141 to 150 of about 47,059 (243)

Co‐occurring opioid and stimulant use disorder and the relationship to severe maternal morbidity

Pregnancy, Volume 2, Issue 4, July 2026.
Abstract Introduction To evaluate the impact of the use of opioids, stimulants, or both on the rates of various severe maternal morbidity (SMM) events during inpatient delivery‐related hospitalizations among patients with substance use disorder (SUD).
Tucker E. Doiron, Noor Al‐Hammadi, Alexandra R. Schroeder, Niraj R. Chavan   +3 more
wiley   +1 more source

Using a controlled stimulant to treat cocaine use disorder in the setting of attention deficit/hyperactivity disorder: a case study. [PDF]

Front Psychiatry
Bozman M, Collier B, Malhotra A, McPherson G, Li L.   +4 more
europepmc   +1 more source

Maternal Deaths Due to Suicide, Accidental Poisoning and Undetermined Intent Within 5 Years Following Childbirth: A Population‐Based Study

BJOG: An International Journal of Obstetrics &Gynaecology, Volume 133, Issue 8, Page 1581-1591, July 2026.
ABSTRACT Objectives Investigate the incidence of maternal deaths by suicide, accidental poisoning and undetermined intent within 5 years following childbirth. Design Linked population‐level data. Setting New South Wales, Australia. Population All women who gave birth from 2002 to 2020. Methods Sociodemographic characteristics, diagnostic and healthcare
Louise Makarious, Ju Lee Oei, Andrew Page, Sadia Hossain, Mithilesh Dronavalli, Hannah Uebel, Evelyn Lee, Michelle Dickson, Lucinda Burns, Barbara Bajuk, John Eastwood, Sithum Munasinghe   +11 more
wiley   +1 more source

Dynamic Alterations in the Blood Transcriptome Characterize Drug Use Behavior and Co-Morbidities in Cocaine Use Disorder: A Preliminary Study. [PDF]

Eur J Neurosci
Nwaneshiudu C, Girdhar K, Kleopoulos SP, Shao Z, Fullard JF, Butelman ER, Parvaz MA, Goldstein RZ, Alia-Klein N, Roussos P.   +9 more
europepmc   +1 more source

Abnormal Brain Structural Covariance Networks of Cortical Thickness in Cocaine Use Disorder

Addiction Biology, Volume 31, Issue 7, July 2026.
Cocaine use disorder (CUD) disrupts large‐scale brain network coordination. Using structural covariance network analysis, we found reduced local clustering, impaired rich‐club connectivity, and a shift toward lattice‐like organization in CUD patients, while global network robustness remained preserved. These findings reveal a dissociation between local
Linkai Chen, Youling Li, Jie Chen, Junshen Zhang, Xinyu Ma, Qiuling Cai, Guanghui Bai, Meimei Du   +7 more
wiley   +1 more source

Combined Naltrexone-Bupropion Therapy for Concurrent Cocaine Use Disorder and Obesity: A Case Report. [PDF]

Reports (MDPI)
Romeo VM.
europepmc   +1 more source

Personalizing smoking cessation pharmacotherapy using neuroaffective reactivity profiles: A randomized controlled trial

Addiction, Volume 121, Issue 7, Page 1888-1898, July 2026.
Abstract Background and aims By assessing neuroaffective response to motivationally relevant cues before a quit attempt, we have shown that smokers who attribute greater incentive salience to cigarette‐related cues than non‐cigarette‐related rewards (Sign‐trackers, ST) benefit more from varenicline compared with smokers with the opposite neuroaffective
Francesco Versace, Charles E. Green, Yong Cui, Jason D. Robinson, Menton M. Deweese, Jennifer A. Minnix, George Kypriotakis, Seokhun Kim, Maher Karam‐Hage, Paul M. Cinciripini   +9 more
wiley   +1 more source

Psilocybin in the Treatment of Cocaine Use Disorder: A Randomized Clinical Trial.

JAMA Netw Open
Hendricks PS, Lappan SN, Shelton RC, Lahti AC, Cropsey KL, Johnson MW, Bradley M, Simonsson O, Davis LL, Grossman DH, Ortiz CE.   +10 more
europepmc   +1 more source

TMS in treatment of Cocaine Use Disorder

Brain Stimulation, 2019
M. Rao, S. Nomura
openaire   +1 more source

Theorizing causality: A qualitative study of xylazine‐related wound diversity and perceived etiology among people who inject drugs

Addiction, Volume 121, Issue 7, Page 1794-1807, July 2026.
Abstract Background and aims Incidence and severity of opioid‐associated skin and soft‐tissue infections, often requiring intensive and costly medical care, have increased substantially since the emergence of xylazine in the US drug supply. Although progress has been made in clinical and harm reduction recommendations for treating xylazine‐related ...
Danielle German, Kelci Villarroel, Meredith Denney, Adrian Guta, Julie Evans, Jason Bienert, Alex Fidler, Kim Ashburn, Zach Kosinski, Becky L. Genberg   +9 more
wiley   +1 more source